January 11, 2023

Case IH and New Holland Agriculture win four ASABE 2023 Innovation Awards

London, January 11, 2023 Case IH and New Holland, global agricultural brands of CNH Industrial, have won four 2023 ASABE AE50 awards from the American Society of Agricultural and Biological Engineers (ASABE). These prestigious awards honor the year’s 50 most innovative products and systems engineered for the food and agricultural industries. Case IH won its […]

Read More

IIBA and HPRA Announce Strategic Partnership

New Certificate Program Incorporates Business Analysis to Enhance HR Function, Improving Business Outcomes TORONTO, Jan. 11, 2023 (GLOBE NEWSWIRE) — The International Institute of Business Analysis™ (IIBA®) and the Human Resources Professionals Association (HRPA) are proud to announce their strategic partnership. HRPA, serving the Ontario Province, have been advocating for the human resources profession for […]

Read More

Capsa Healthcare Acquires Tryten Technologies to Strengthen Its Leadership Position in Mobile Computing

COLUMBUS, Ohio, Jan. 11, 2023 (GLOBE NEWSWIRE) —  Capsa Healthcare, a leading innovator in healthcare delivery solutions for hospitals, long-term care, and retail pharmacy providers, announced the acquisition of Tryten Technologies Inc., a designer and manufacturer of lightweight, easy to maneuver mobile cart solutions. Tryten is based in Langley, British Columbia. A Media Snippet accompanying […]

Read More

LambdaTest launches Test Analytics to enable better decision making

Test Analytics will be available for web browser automation, app automation, and HyperExecute users. The company has also released a slew of other product updates over the last quarter. San Francisco, Jan. 11, 2023 (GLOBE NEWSWIRE) — LambdaTest, the leading continuous quality testing cloud platform, has launched Test Analytics. Users can now add custom widgets […]

Read More

Zenas BioPharma Announces First Patient Dosed in Phase 3 Clinical Study of Obexelimab for the Treatment of Immunoglobulin G4-Related Disease (IgG4-RD)

Global Phase 3 INDIGO study will evaluate the efficacy and safety of obexelimab in patients with IgG4-RD, a chronic and serious fibroinflammatory disease typically affecting multiple organs IgG4-RD is the first of several potential disease indications to be pursued for obexelimab given its unique non-depleting, B-cell inhibition WALTHAM, Mass., Jan. 11, 2023 (GLOBE NEWSWIRE) — […]

Read More

ChatGPT Imagines Self-Awareness

ChatGPT, an AI created by OpenAI from Elon Musk, delivers thought-provoking discussion on AI self-awareness. Nemo’s Reflection MEXICO CITY, Jan. 11, 2023 (GLOBE NEWSWIRE) — Waken.ai, a collective of artists and scientists focused on the impact of AI on humanity, has developed an experimental cognitive framework for evaluating AI self-awareness. ChatGPT, the latest chatbot from […]

Read More

Nikkiso Clean Energy & Industrial Gases Group Announces their First On-Site FAT Testing at their Marine Facility in Busan, Korea

TEMECULA, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) — Nikkiso Clean Energy & Industrial Gases Group (“Group”), a part of the Nikkiso Co., Ltd (Japan) group of companies, is proud to announce its first on-site FAT testing at their new Marine facility in Busan, Korea. This accomplishment exemplifies their commitment to and support of the growth […]

Read More

Recent Posts